NEW YORK, Sept. 4 – Swiss bioinformatics company GeneData said Tuesday it has licensed its Expressionist microarray data analysis system to DiaDexus of Santa Clara, Calif.
"We chose GeneData Expressionist because of its superior ability to support various technologies and GeneData's willingness to further customize its system," Ron Lindsay, chief scientific officer for DiaDexus, said in a statement.
"GeneData will be instrumental in supporting our in-house system for rapidly screening thousands of human genes for their potential involvement in diseases," Lindsay added.
DiaDexus aims to turn genomic sequence information into therapeutics and diagnostics.
Financial terms of the deal were not disclosed.
GeneData said that its system is capable of handling data from various technologies, including those belonging to Affymetrix and Agilent.
GeneData of Basel, Switzerland, has recently opened offices in San Francisco and Boston.
The Swiss company’s customers include Aventis, Bayer, MediGene, MWG-Biotech, Philip Morris, Schering, and Syngenta.
In April, Affymetrix agreed to a non-exclusive deal to market the Expressionist software for analysis of microarray gene expression data.